A comparison of second and third generations combined oral contraceptive pills’ effect on mood

Iranian Red Crescent Medical Journal

Volumn 16, Issue 8, 2014, Pages

  Shahnazi, Mahnaz ^a   Khalili, Azizeh Farshbaf ^a   Kochaksaraei, Fatemeh Ranjbar ^a   Jafarabadi, Mohammad Asghari ^a   Banoi, Kamal Gaza ^a   Nahaee, Jila ^a   Payan, Somayeh Bayati ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Administration; Contraceptive agents; Mood disorders; Oral

Indexed keywords

DESOGESTREL; ESTROGEN; ETHINYLESTRADIOL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMAN; MIDDLE AGED; MOOD CHANGE; POSITIVE AND NEGATIVE AFFECT SCHEDULE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

EID: 84964411040     PISSN: 20741804     EISSN: 20741812     Source Type: Journal    
DOI: 10.5812/ircmj.13628     Document Type: Article

References (27)

1. Træen B, Gravningen K. The Use of Protection for Sexually Transmitted Infections (STIs) and Unwanted Pregnancy among Norwegian Heterosexual Young Adults 2009. Sex Cult. 2011;15(2):195-212.
2. Kelly S, Davies E, Fearns S, McKinnon C, Carter R, Gerlinger C, et al. Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study. Clin Drug Investig. 2010;30(5):325-36.
3. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64(1):51-8.
4. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. Am J Obstetric Gynecol. 1998;179(3):577-82.
5. Lindh I, Blohm F, Andersson-Ellstrom A, Milsom I. Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population. Contraception. 2009;80(2):163-9.
6. Segebladh B, Borgstrom A, Odlind V, Bixo M, Sundstrom-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009;79(1):50-5.
7. Ryan KJ. Kistner’s Gynecology and Women’s Health. Mosby; 1999.
8. Berek JS, Adashi EY, Hillard PA. Novak’s gynecology. Maryland: West Camden Street: Williams and Wilkins Baltimore. 2012. p.159.
9. Dalton ME. Sex hormone-binding globulin concentrations in women with severe premenstrual syndrome. Postgrad Med J. 1981;57(671):560-1.
10. Baischer W, Koinig G, Hartmann B, Huber J, Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology. 1995;20(5):553-9.
11. Vogel W, Klaiber EL, Broverman DM. Roles of the gonadal steroid hormones in psychiatric depression in men and women. Prog Neuropsychopharmacol. 1978;2(4):487-503.
12. Luthold WW, Borges MF, Marcondes JA, Hakohyama M, Wajchenberg BL, Kirschner MA. Serum testosterone fractions in women: normal and abnormal clinical states. Metabolism. 1993;42(5):638-43.
13. Poromaa IS, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand. 2012;91(4):420-7.
14. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995;51(5):283-8.
15. Kay CR. The Royal College of General Practitioners’ Oral Contraception Study: some recent observations. Clin Obstet Gynaecol. 1984;11(3):759-86.
16. Kurshan N, Neill Epperson C. Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch Womens Ment Health. 2006;9(1):1-14.
17. Khosravi A. Health indicators in the Islamic Republic of Iran Broadcasting. 1st ed. Kermanshah: Health Research Center, Kermanshah University of Medical Sciences and Health Services; 2010.
18. Malekian S. Comparison of Oral l. Dee and condoms on sexual function in female patients 19-49 years of health care coverage in 2008. Tehran: Tehran University of Medical Sciences; 2009.
19. Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43(Pt 3):245-65.
20. O’Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13-21.
21. Sitruk-Ware R. New progestagens for contraceptive use. Hum. Reprod. Update. 2005;12(2):169-78.
22. Nyberg S. Mood and physical symptoms improve in women with severe cyclical changes by taking an oral contraceptive containing 250-mcg norgestimate and 35-mcg ethinyl estradiol. Contraception. 2013;87(6):773-81.
23. Gingnell M, Engman J, Frick A, Moby L, Wikstrom J, Fredrikson M, et al. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013;38(7):1133-44.
24. Yusefzadeh S. Survey on the efficacy and complications off different contraceptive in women. Asrar. 2008;7(2):43-53.
25. Janabi A, Ghodsi Z. valuation of the reasons for the lack of consistency and continuity in health centers Tvsyrgan oral LD. Med J Soc Secur. 2006;6(34):58-155.
26. Habibi M, L-Rasoulian M. Contraceptive pills associated with symptoms of depression and anxiety. 2010.
27. Jarva JA, Oinonen KA. Do oral contraceptives act as mood stabilizers? Evidence of positive affect stabilization. Arch Womens Ment Health. 2007;10(5):225-34.